Akebia Therapeutics Inc (AKBA)
1.79
-0.07
(-3.76%)
USD |
NASDAQ |
Jan 08, 16:00
1.78
-0.01
(-0.56%)
After-Hours: 20:00
Akebia Therapeutics Total Assets (Quarterly): 207.14M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Aldeyra Therapeutics Inc | 117.32M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 257.54M |
| Shareholders Equity (Quarterly) | -50.40M |
| Debt to Equity Ratio | -0.761 |
| Current Ratio | 1.524 |
| Net Debt Paydown Yield | 0.30% |